收藏切换
New progress on belizumab in the treatment of systemic lupus erythematosus
收藏切换
Qingling YANG1, 2, Guangtao XIA2, *
World Clinical Drug | 2022, 43(1) : 15 - 18
Less
收藏切换
World Clinical Drug | 2022, 43(1): 15-18
• Topic •
New progress on belizumab in the treatment of systemic lupus erythematosus
Full
Qingling YANG1, 2, Guangtao XIA2, *
Affiliations
  • 1.Department of Rheumatology, Shouguang Hospital of Traditional Chinese Medicine, Weifang 262799, Shandong Province, China
  • 2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China
Published: 2022-01-10 doi: 10.13683/j.wph.2022.01.004
Outline
收藏切换

Systemic lupus erythematosus (SLE) is a chronic diffuse connective tissue disease involving multiple systems of the whole body. The etiology and mechanism are not completely clear. At present, the treatment of SLE is still dominated by traditional drugs, such as non steroidal anti-inflammatory drugs, glucocorticoids and immunosuppressants, etc. In recent years, with the continuous improvement of the level of molecular targeted therapy, relevant academic circles have begun to pay extensive attention to biological agent therapy. Compared with traditional treatment methods, biological agents have a selective effect on self reactive lymphocytes or inflammatory mediators, which can reduce the damage of immune function and the incidence of adverse reactions. Belizumab is a medical biological agent and the first inhibitor of B lymphocyte stimulating factor. This paper reviewed the new progress of belizumab in the treatment of SLE, in order to provide reference for clinical diagnosis and treatment.

belizumab  /  systemic lupus erythematosus  /  biological agent
杨庆玲, 夏光涛. 贝利尤单抗在系统性红斑狼疮治疗中的新进展. 世界临床药物, 2022 , 43 (1) : 15 -18 . DOI: 10.13683/j.wph.2022.01.004
Qingling YANG, Guangtao XIA. New progress on belizumab in the treatment of systemic lupus erythematosus[J]. World Clinical Drug, 2022 , 43 (1) : 15 -18 . DOI: 10.13683/j.wph.2022.01.004
Year 2022 volume 43 Issue 1
9
1
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.01.004
  • Receive Date:2021-10-13
  • Online Date:2026-11-19
  • Published:2022-01-10
Article Data
Affiliations
History
  • Received:2021-10-13
Funding
Affiliations
    1.Department of Rheumatology, Shouguang Hospital of Traditional Chinese Medicine, Weifang 262799, Shandong Province, China
    2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.01.004
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT